AzTrials
AzTrials

StrokeNCT04550793

Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients

An observational study of Stroke and Spasticity, Muscle, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Spasticity of stroke patient, a very common complication in clinical practice, affects performance of hand function and gait pattern. It also interferes with quality of life of patients severely. Currently first line clinical approach to spasticity consist of physical therapy and pharmacological management. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Stroke, Spasticity, Muscle, Botulism
What is being tested?
Botulinum toxin injection
Type of treatment
Injection or infusion
How many people
100 participants
Where
1 siteTaiwan
Study dates
Sep 2020to Dec 2021
How long will I take part?
12 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke patient aged above 20 years old with unilateral involvement.

Who may be able to join

  • [Intervention group]
  • Stroke patients with unilateral involvement
  • Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale
  • Patient required botulinum toxin injection at affected upper limb muscle per primary care physician.
  • [Control group]
  • Stroke patients with unilateral involvement
  • Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale

Who cannot join

  • Patients ever diagnosed with cerebral diseases other than stroke, such as traumatic brain injury, encephalitis and brain tumor
  • Patients failed to cooperated due to cognition, consciousness or speech problem
  • Patients with illness that could affect muscle stiffness, such as spinal cord injury and Parkinson's disease
  • Patients with upper limb contracture
  • Patients receiving botulinum toxin injection or shock wave therapy over upper extremities during past three months

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Taiwan University Hospital

    Taipei, 100

Other trials in Taiwan

About this study

Spasticity of stroke patient, a very common complication in clinical practice, affects performance of hand function and gait pattern. It also interferes with quality of life of patients severely. Currently first line clinical approach to spasticity consist of physical therapy and pharmacological management. However, there are still some refractory cases that needed local intervention such as Botox injection.

So far, we only can use subjective methods to measure muscle tension, such as modified Ashworth scale and Tone Assessment Scale. In our previous study, we found that ultrasound shear wave image could correlate with muscle stiffness caused by poststroke spasticity. With this new method, we aim to establish a more objective method in measuring abnormal poststroke muscle tension before and after treatments and further monitor therapeutic effect. We also include several assessment scales to evaluate the correlation between measured muscle spasm and activity of daily living.

Read more

We hypothesize that the rheological changes in muscles muscle spasm after Botox injection can be detected by ultrasound shear wave image. Therapeutic effect can also be seen in its effect on daily functions.

In this project, we will use shear wave imaging of ultrasound to investigate the elasticity (and hardness) of the biceps brachii and brachialis muscle in stroke patients with unilateral hemiplegia before and after Botox injection. The findings of this project will provide the objective evaluation of muscle spasticity and its correlation with functional status, which will provide new points of view toward treatment of spasticity.

Being tested
Botulinum toxin injection
Medical subject headings
Stroke, Muscle Spasticity, Botulism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Botulinum toxin injectionDrug

    Botulinum toxin injection at affected brachialis and/or biceps brachials.

Study groups in NCT04550793
Study groupRoleWhat they receive
InterventionThe stroke patients who receive botulinum toxin injection at affected brachialis and/or biceps brachials.
Receives: Drug: Botulinum toxin injection
ControlThe stroke patients who do not receive botulinum toxin injection at affected brachialis and/or biceps brachials in the past 3 months.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Shear Wave Ultrasound Elastography

    Shear wave ultrasound elastography measurement of spastic upper limb muscles, including biceps brachii and brachialis

    Measured: During each follow up visit within 12 weeks time frame

Secondary outcomes (10)
  1. Barthel Index (Wade's version)

    Barthel Index assessing activities of daily livings

    Measured: During each follow up visit within 12 weeks time frame

  2. Revised Nottingham Extended Activities of Daily Livings Scale

    Revised Nottingham Extended Scale assessing activities of daily livings

    Measured: During each follow up visit within 12 weeks time frame

  3. Stroke Rehabilitation Assessment of Movement (STREAM), brief version

    STREAM assessing movement condition

    Measured: During each follow up visit within 12 weeks time frame

  4. Modified Ashworth Scale (MAS)

    MAS scale for assessing spasticity

    Measured: During each follow up visit within 12 weeks time frame

  5. Tone Assessment Scale (TAS)

    TAS scale for assessing spasticity

    Measured: During each follow up visit within 12 weeks time frame

  6. Global improvement scale

    Global improvement scale for assessing symptoms related to stroke

    Measured: During each follow up visit within 12 weeks time frame

  7. Self-report spasticity symptoms

    Self-report spasticity symptoms for assessing spasticity

    Measured: During each follow up visit within 12 weeks time frame

  8. EuroQol

    EuroQol for evaluating quality of life

    Measured: During each follow up visit within 12 weeks time frame

  9. Extended Activities of Daily Living

    Extended Activities of Daily Living scale for evaluating activity of daily living

    Measured: During each follow up visit within 12 weeks time frame

  10. Postural Assessment Scale for Stroke Patients (PASS), brief version

    PASS for evaluating symptoms related to stroke

    Measured: During each follow up visit within 12 weeks time frame

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2020
  2. Study startSep 2020 (estimated)
  3. Primary completionDec 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
12 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT04550793
Sponsor's protocol ID
202006138RINB
Status last verified
Jul 2020
First submitted
9 Sep 2020
Last updated
16 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Spasticity, Muscle, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Huey-Wen Liang, MD PHD (886-2-23123456 ext. 66697, ntuhpmr.4124@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Shear Wave Ultrasound Elastography (time frame: During each follow up visit within 12 weeks time frame). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in